{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:10Z","timestamp":1755216730438,"version":"3.43.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>Laminin alpha-2-related muscular dystrophy (<jats:italic toggle=\"yes\">LAMA2<\/jats:italic>-MD), caused by mutations in the <jats:italic toggle=\"yes\">LAMA2<\/jats:italic> gene, is inherited in an autosomal recessive manner. There is no known association of <jats:italic toggle=\"yes\">LAMA2<\/jats:italic>-MD with cancer predisposition. We present a 4-year-old female with <jats:italic toggle=\"yes\">LAMA2<\/jats:italic>-MD and Children\u2019s Oncology Group stage III diffuse anaplastic Wilms tumor (DAWT). Given our patient\u2019s comorbidities, it was essential to tailor her adjuvant chemotherapy by omitting vincristine and doxorubicin to avoid the potential worsening of her neuromuscular dysfunction and cardiomyopathy. This report illustrates the sporadic occurrence of 2 rare events in our patient and highlights the successful risk-adapted management of DAWT based on the pathophysiology of <jats:italic toggle=\"yes\">LAMA2<\/jats:italic>-MD.<\/jats:p>","DOI":"10.1097\/mph.0000000000002503","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T15:00:06Z","timestamp":1655910006000},"page":"474-478","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Anaplastic Wilms Tumor in a Child With LAMA2-related Muscular Dystrophy"],"prefix":"10.1097","volume":"44","author":[{"given":"Rachana","family":"Shah","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Cancer and Blood Disease Institute"},{"name":"Division of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deena","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Cancer and Blood Disease Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh M.","family":"Ramos-Platt","sequence":"additional","affiliation":[{"name":"Division of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy C.","family":"Grikscheit","sequence":"additional","affiliation":[{"name":"Division of Neurology"},{"name":"Departments of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengmei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Division of Neurology"},{"name":"Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth K.","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Neurology"},{"name":"Radiation Oncology, Children\u2019s Hospital Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Mascarenhas","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Cancer and Blood Disease Institute"},{"name":"Division of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.ejhg.5200743","article-title":"Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin)","volume":"10","author":"Allamand","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.matbio.2017.11.009","article-title":"Laminin-deficient muscular dystrophy: molecular pathogenesis and structural repair strategies","volume":"71-72","author":"Yurchenco","year":"2018","journal-title":"Matrix Biol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nmd.2010.02.001","article-title":"Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations","volume":"20","author":"Geranmayeh","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0002-8703(98)70222-4","article-title":"Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy","volume":"136","author":"Spyrou","year":"1998","journal-title":"Am Heart J"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jmg.38.10.649","article-title":"The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review","volume":"38","author":"Jones","year":"2001","journal-title":"J Med Genet"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0887-8994(01)00352-6","article-title":"Nonmuscular involvement in merosin-negative congenital muscular dystrophy","volume":"26","author":"Gilhuis","year":"2002","journal-title":"Pediatr Neurol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/mus.22228","article-title":"Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-\u03b12-chain gene: a chance association or a novel phenotype?","volume":"44","author":"Carboni","year":"2011","journal-title":"Muscle Nerve"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1177\/0883073810381924","article-title":"Consensus statement on standard of care for congenital muscular dystrophies","volume":"25","author":"Wang","year":"2010","journal-title":"J Child Neurol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1096-8652(200101)66:1<46::AID-AJH1007>3.0.CO;2-O","article-title":"\u201cLiver function tests\u201d are not always tests of liver function","volume":"66","author":"Korones","year":"2001","journal-title":"Am J Hematol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.2005.04.7852","article-title":"Treatment of anaplastic histology Wilms\u2019 tumor: results from the fifth National Wilms\u2019 Tumor Study","volume":"24","author":"Dome","year":"2006","journal-title":"JCO"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1200\/JCO.1994.12.10.2126","article-title":"Treatment of children with stages II to IV anaplastic Wilms\u2019 tumor: a report from the National Wilms\u2019 Tumor Study Group","volume":"12","author":"Green","year":"1994","journal-title":"J Clin Oncol"},{"issue":"S2","key":"R15-20250804","first-page":"S105","article-title":"Toronto, Canada, 22(nd) -25(th) October, 2014 SIOP Abstracts","volume":"61","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"suppl 15","key":"R16-20250804","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1200\/jco.2014.32.15_suppl.10032","article-title":"A phase 2 study of vincristine and irinotecan in metastatic diffuse anaplastic Wilms tumor: results from the Children\u2019s Oncology Group AREN0321 study","volume":"32","author":"Daw","year":"2014","journal-title":"JCO"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.urolonc.2015.10.012","article-title":"Current standards of care and future directions for \u201chigh-risk\u201d pediatric renal tumors: anaplastic Wilms tumor and Rhabdoid tumor","volume":"34","author":"Geller","year":"2016","journal-title":"Urol Oncol"},{"key":"R18-20250804","first-page":"1499","article-title":"Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class","volume":"36","author":"Owellen","year":"1976","journal-title":"Cancer Res"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1158\/0008-5472.CAN-09-4281","article-title":"Microtubule-disrupting chemotherapeutics result in enhanced proteasome-mediated degradation and disappearance of tubulin in neural cells","volume":"70","author":"Huff","year":"2010","journal-title":"Cancer Res"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pbc.22882","article-title":"Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children\u2019s Oncology Group","volume":"57","author":"Langholz","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.apmr.2013.03.009","article-title":"Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study","volume":"94","author":"Ness","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/EDBK_100015","article-title":"Predicting and preventing anthracycline-related cardiotoxicity","volume":"38","author":"Armenian","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2001.19.7.1926","article-title":"Congestive heart failure after treatment for Wilms\u2019 tumor: a report from the National Wilms\u2019 Tumor Study Group","volume":"19","author":"Green","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:02:48Z","timestamp":1754337768000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002503","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"2021-09-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}